LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
29.89
-2.05 (-6.42%)
At close: Nov 25, 2025, 4:00 PM EST
29.88
-0.01 (-0.03%)
After-hours: Nov 25, 2025, 4:04 PM EST
LENZ Therapeutics Revenue
LENZ Therapeutics had revenue of $12.50M in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $17.50M.
Revenue (ttm)
$17.50M
Revenue Growth
n/a
P/S Ratio
50.96
Revenue / Employee
$1,590,909
Employees
11
Market Cap
935.26M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 15.00M | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionLENZ News
- 31 minutes ago - LENZ Therapeutics to Present at Upcoming Investor Conferences - GlobeNewsWire
- 20 days ago - LENZ Therapeutics, Inc. (LENZ) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 20 days ago - LENZ Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 27 days ago - LENZ Therapeutics to Report Third Quarter 2025 Financial Results and Recent Corporate Highlights on November 5, 2025 - GlobeNewsWire
- 2 months ago - LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States - PRNewsWire
- 2 months ago - LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States - GlobeNewsWire
- 2 months ago - LENZ Therapeutics, Inc. (LENZ) Therapeutics, Inc. Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - LENZ Therapeutics, Inc. (LENZ) Therapeutics, Inc. Presents At Citi's Biopharma Back To School Conference Transcript - Seeking Alpha